TFPI2 and neoplasm: TFPI-2 is thought to interact with actinin-4 and myosin-9 in the cytoplasm, with AP-2α in the nucleus and with the ERK-signaling pathway, affecting nuclear localization of pERK1/2, which, as a result, causes inhibition of tumor cell motility, proliferation and invasion [107].